Experience of using atezolizumab in 1st line therapy of metastatic urothelial cancer
The article presents 2 clinical examples of using a PD-L1 inhibitor atezolizumab in treatment of urothelial cancer. In the 1st clinical case of bladder cancer, due to concomitant pathology any platinum-containing therapy was impossible. After 9 months of treatment with atezolizumab target lesions de...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2019-10-01
|
| Series: | Onkourologiâ |
| Subjects: | |
| Online Access: | https://oncourology.abvpress.ru/oncur/article/view/988 |